Diprolene Ointment for inflammatory skin conditions in patients 13 years and older

Diprolene is a super-high-potency topical corticosteroid ointment containing betamethasone dipropionate. It is approved for use in patients 13 years and older to relieve inflammation and itching caused by corticosteroid-responsive skin diseases such as psoriasis and atopic dermatitis.

Diprolene Ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients aged 13 years and older. It is used topically for conditions such as psoriasis and atopic dermatitis.

betamethasone dipropionate

Diprolene contains betamethasone dipropionate, a corticosteroid that works by reducing inflammation and immune responses in the skin. While its precise mechanism in treating skin conditions is not fully understood, corticosteroids generally modify cellular signaling, immune function, and inflammation to relieve symptoms.

Vasoconstrictor studies showDiprolene Ointment has super-high potency compared to other topical corticosteroids.

Adults and patients 13 years and older:

• Apply a thin film of Diprolene Ointment to affected skin areas one or two times daily.
• Do not exceed 50 grams per week.
• Treatment duration should not exceed 2 consecutive weeks.
• Discontinue therapy when control is achieved or if no improvement occurs after 2 weeks; reassess diagnosis if needed.
• Do not use occlusive dressings unless directed by a physician.
• Avoid applying to face, axillae (underarms), groin, or areas with skin atrophy.

Important administration instructions: Use Diprolene Ointment only topically; it is not for oral, ophthalmic, or intravaginal use. Avoid contact with eyes and wash hands after application (unless treating the hands).

Pediatric use: Not recommended for children under 13 years due to risk of hypothalamic-pituitary-adrenal (HPA) axis suppression.

Diprolene Ointment is contraindicated in patients with known hypersensitivity to betamethasone dipropionate, other corticosteroids, or any ingredient in the preparation.

Endocrine effects: Diprolene Ointment can cause reversible suppression of the hypothalamic-pituitary-adrenal (HPA) axis, potentially leading to glucocorticosteroid insufficiency during or after treatment. Risk factors include use of high-potency steroids, large surface area application, prolonged use, occlusive dressings, altered skin barrier, liver failure, and young age. If suppression occurs, gradually withdraw treatment, reduce frequency, or switch to a less potent steroid.

Ophthalmic risks: Use may increase risk of cataracts and glaucoma. Avoid contact with eyes. Patients should report visual symptoms promptly and may require ophthalmologic evaluation.

Allergic contact dermatitis: May occur and is typically indicated by failure to heal rather than worsening. Discontinue if irritation develops.

Other precautions: Avoid use on face, groin, axillae, or skin with atrophy. Do not use with occlusive dressings unless directed by a physician.

The most common side effects occurring in less than 1% of patients include redness (erythema), inflamed hair follicles (folliculitis), itching (pruritus), and blistering (vesiculation).

Postmarketing reports include local reactions such as skin atrophy, telangiectasias, burning, irritation, dryness, acne-like eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infections, increased hair growth (hypertrichosis), stretch marks (striae), and miliaria.

Hypersensitivity reactions with skin symptoms like contact dermatitis, pruritus, bullous dermatitis, and rash have also been reported.

Ophthalmic adverse effects reported include cataracts, glaucoma, increased intraocular pressure, and central serous chorioretinopathy.

Concurrent use of systemic corticosteroids or other topical corticosteroid products may increase the risk of systemic adverse effects and HPA axis suppression. Avoid using other corticosteroid-containing medications without consulting a healthcare provider.

Pregnancy: There are no well-controlled studies of Diprolene Ointment in pregnant women. Observational data suggest potential increased risk of low birthweight infants with high total doses of potent topical corticosteroids during pregnancy. Animal studies showed malformations with systemic betamethasone dipropionate. Use during pregnancy only if needed, on the smallest area and shortest duration.

Lactation: It is unknown if betamethasone dipropionate passes into breast milk after topical use. Use cautiously during breastfeeding on the smallest area and shortest duration possible. Avoid applying directly to nipple and areola to prevent infant exposure.

Excessive use may lead to systemic corticosteroid effects such as HPA axis suppression, Cushing's syndrome, and hyperglycemia. Supportive measures and gradual withdrawal of corticosteroid are recommended. Monitor patients for signs of adrenal insufficiency and treat accordingly.

Store Diprolene Ointment at controlled room temperature 25°C (77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F).